Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Chinese Pharmaceutical Journal》 2005-03
Add to Favorite Get Latest Update

Research on hippocampus capsule therapy of experimental benign prostatic hyperplasia

MENG Xue-qiang~1 ,XU Dong-hui~1* ,MEI Xue-ting~1 ,XU Shi-bo~1 ,L Jun-yi~2 , LI Bing-ji~3 (1. School of Pharmaceutical Sciences,Sun Yan-sen University, Guangzhou 510275,China;2. Richvast Ocean Bio-tech Research Center of Zhongshan University, Guangzhou 510275,China;3. Guangdong Zhongda Richvast Group Co.,Ltd,Lufeng 516500,China)  
OBJECTIVE To study the pharmacological effects of hippocampus capsule on experimental benign prostatic hyperplasia(BPH). METHOD The rat model was made by injecting testosterone propianate (TP) to castrated rats, the mouse model was made by transplanting urogenital sinus(UGS) to the prostates of mature male mice. RESULTS In the rat BPH model, hippocampus capsule reduced the weight and index of ventral prostate, dorsal prostate and seminal vesicle, reduced the levels of serum ACP and serum Zn, and increased the NO level in ventral prostate. In the mouse BPH model, hippocampus capsule reduced the weight and index of ventral prostate and dorsal prostate, and the levels of serum ACP and serum Zn. CONCLUSION Hippocampus capsule can be used in the treatment of experimental BPH.
【Fund】: 国家海洋863资助课题(2002AA624010 2003AA620408)
【CateGory Index】: R285.5
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved